| | | | | | | | | | | |
| KOMISJA NADZORU FINANSOWEGO | |
| | | | | | | | | | | | |
|
| | Raport bieżący nr | 13 | / | 2022 | |
| |
| | | | | | | | | | | | |
| Data sporządzenia: | 2022-09-23 | | | | | | | | | |
| Skrócona nazwa emitenta | | | | | | | | | |
| MILESTONE MEDICAL | |
| | | | | | | | | | |
| Temat | | | | | | | | | | |
| List of Shareholders representing at least 5 % of the number of votes at the Annual General Meeting of the Shareholders on September 23, 2022 | |
| Podstawa prawna | | | | | | | | |
| Art. 70 pkt 3 Ustawy o ofercie - WZA lista powyżej 5 %
| |
| | | | | | | | | | | | |
| Treść raportu: | | | | | | | | | |
| The Board of Directors of Milestone Medical Inc, the "Company , hereby informs that the entities named below were shareholders representing at least 5% of the number of votes at the Annual General Meeting of Shareholders held in New Jersey, USA, on September 23, 2022 the Meeting"
- Milestone Scientific Inc.- the shares held in the Company vested in Milestone Scientific the right of 21,633,084 votes at the Meeting, which accounted for 100% of the votes of the Shareholders present at the Meeting and for 98.33% of the total number of votes. | |
| | | | | | | | | | | | |
| | | | | |
| PODPISY OSÓB REPREZENTUJĄCYCH SPÓŁKĘ | |
| Data | Imię i Nazwisko | Stanowisko/Funkcja | Podpis | |
| 2022-09-23 | Keisha Harcum | Controller | Keisha Harcum | |
| | | | | |
